Emyria Limited (EMD.AX)
Develops mental health treatments using MDMA and CBD for depression and PTSD.
0.05-0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+2.2%
The outlook
EMD.AX is trading near the lower end of its 52-week range and showing mixed momentum against its moving averages. Analyst coverage appears thin or unavailable for this stock. The overall sentiment leans bearish based on current technical positioning.
What’s behind the score
Price trendMixed vs its moving averages
52-week range26% of the way from its 52-week low to high
Market cap
$37.9M
52-wk high
0.08
52-wk low
0.04
50-day avg
0.04
200-day avg
0.05
Trailing P/E
—